Evidence map›Paper›PMID 41181044›Full record

ArticleWorld journal of orthopedics2025

Expanding role of VISA-P in patellofemoral pain assessment-case for caution and context.

Conor J Ledingham, Paul O'Grady

Abstract readEditorial
In one paragraph

Article in World journal of orthopedics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Conor J LedinghamDepartment of Orthopaedics, Mayo University Hospital, Castlebar F23 F990, Mayo, Ireland.
Paul O'GradyDepartment of Trauma and Orthopaedic Surgery, Mayo University and Galway University Hospitals, Castelbar F23 H529, Ireland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The VISA-P originally developed to assess patellar tendinopathy severity, is increasingly being applied to patellofemoral pain (PFP) assessment. This editorial examines the expanding role of VISA-P within the context of existing patient-reported outcome measures (PROMs) for PFP, such as the Kujala Anterior Knee Pain Scale and the Knee injury and Osteoarthritis Outcome Score for Patellofemoral Pain and Osteoarthritis. While VISA-P offers advantages in brevity, readability, and temporal stability, its original design targeting athletic populations with patellar tendinopathy limits its specificity and comparability when applied broadly to heterogeneous PFP populations. Moreover, VISA-P currently lacks validated diagnostic thresholds to guide clinical decision-making. Although the recent validation of VISA-P in Spanish-speaking populations enhances accessibility, caution is advised in its widespread adoption without clear delineation of its role relative to other PROMs. The editorial argues for careful contextual use of VISA-P, emphasizing the need for tools that balance specificity, efficiency, and universality to capture the complex spectrum of PFP across diverse populations.

Indexed as

AthleticKneePatellofemoral painPatient-reported outcome measureVISA-P

Identifiers

PMID41181044
PMCPMC12576717

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.